Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
在临床前可逆性黑色素瘤小鼠模型中，针对 PD-L1 的免疫检查点抑制剂疗法在心脏中具有耐受性，且未出现心脏炎症表现
期刊:Frontiers in Molecular Medicine
影响因子:
doi:10.3389/fmmed.2024.1487526
Caroline Schoenherr #, Stefan Pietzsch #, Cristina Barca, Franziska E Müller, Frauke S Bahr, Martina Kasten, Andre Zeug, Sergej Erschow, Christine S Falk, Evgeni Ponimaskin, James T Thackeray, Denise Hilfiker-Kleiner, Melanie Ricke-Hoch
免疫
黑色素瘤
ELISA
Checkpoint
Mouse
CD45
